Publications

Title

Author

Year

Correction to: Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study.

Chang, ST; Chihota, VN; FIELDING, KL; GRANT, AD; HOUBEN, RM; WHITE, RG; Churchyard, GJ; Eckhoff, PA; Wagner, BG;

2018

BMC MEDICINE, (2018).16 1 10.1186/s12916-018-1238-9.

Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines.

Pelzer, PT; SEELEY, J; Sun, FY; Tameris, M; Tao, L; Yanlin, Z; Moosan, H; WEERASURIYA, C; Asaria, M; Jayawardana, S; WHITE, RG; Harris, RC;

2018

PLOS Global Public Health, (2018).2 5 10.1371/journal.pgph.0000076.

Transmission of drug-resistant tuberculosis in HIV-endemic settings.

KHAN, PY; Yates, TA; Osman, M; Warren, RM; Van der Heijden, Y; Padayatchi, N; Nardell, EA; MOORE, D; Mathema, B; Gandhi, N; Eldholm, V; DHEDA, K; Hesseling, AC; Mizrahi, V; Rustomjee, R; Pym, A;

2018

LANCET INFECTIOUS DISEASES, (2018).19 3 10.1016/S1473-3099(18)30537-1.

Metabolite changes in blood predict the onset of tuberculosis.

Weiner, J; Maertzdorf, J; SUTHERLAND, JS; Duffy, FJ; Thompson, E; Suliman, S; McEwen, G; Thiel, B; Parida, SK; Zyla, J; Hanekom, WA; Mohney, RP; Boom, WH; Mayanja-Kizza, H; Howe, R; DOCKRELL, HM; Ottenhoff, TH M; Scriba, TJ; Zak, DE; Walzl, G; Kaufmann, SH E; GC6-74 consortium,;

2018

Nature Communications, (2018).9 1 10.1038/s41467-018-07635-7.

Validation of the FluoroType<sup>®</sup> MTBDR assay using respiratory and lymph node samples.

Haasis, C; Rupp, J; Andres, S; Schlüter, B; Kernbach, M; Hillemann, D; KRANZER, K;

2018

Tuberculosis (Edinburgh, Scotland), (2018).113, 10.1016/j.tube.2018.09.004.

Intra-individual effects of food upon the pharmacokinetics of rifampicin and isoniazid.

Requena-Méndez, A; Davies, G; Waterhouse, D; Ardrey, A; Jave, O; López-Romero, SL; Ward, SA; MOORE, DA J;

2018

The Journal of antimicrobial chemotherapy, (2018).74 2 10.1093/jac/dky444.

Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru.

Obregón, G; Zevallos, K; Alarcón, V; Puyén, ZM; Chávez Inagaki, O; Mendoza-Ticona, A; Alarcón-Arrascue, E; Heldal, E; MOORE, DA J;

2018

The international journal of tuberculosis and lung disease, (2018).22 11 10.5588/ijtld.17.0894.

Tuberculosis in children treated with second-line drugs under programmatic conditions in Lima, Peru.

Villarreal, J; Alarcón, V; Alarcón-Arrascue, E; MOORE, DA J; Heldal, E; Mendoza-Ticona, A;

2018

The international journal of tuberculosis and lung disease, (2018).22 11 10.5588/ijtld.17.0911.

The Importance of Heterogeneity to the Epidemiology of Tuberculosis.

Trauer, JM; Dodd, PJ; Gomes, MG M; Gomez, GB; HOUBEN, RM G J; McBryde, ES; Melsew, YA; Menzies, NA; Arinaminpathy, N; Shrestha, S; Dowdy, DW;

2018

Clinical infectious diseases, (2018).69 1 10.1093/cid/ciy938.

Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia.

Dale, KD; Trauer, JM; Dodd, PJ; HOUBEN, RM G J; Denholm, JT;

2018

The European respiratory journal, (2018).52 6 10.1183/13993003.01218-2018.